{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:36:34Z","timestamp":1791074194605,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.pscychresns.2009.03.004","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T11:09:17Z","timestamp":1245928157000},"page":"143-149","source":"Crossref","is-referenced-by-count":27,"title":["Oral glycine administration increases brain glycine\/creatine ratios in men: A proton magnetic resonance spectroscopy study"],"prefix":"10.1016","volume":"173","author":[{"given":"Marc J.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Prescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"Ongur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Eden","family":"Evins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa L.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Covell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry F.","family":"Renshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2009.03.004_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0010-406X(69)90571-4","article-title":"A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates","volume":"28","author":"Aprison","year":"1969","journal-title":"Comparative Biochemistry and Physiology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.npp.1300845","article-title":"Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking","volume":"31","author":"Backstrom","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mrm.1910320304","article-title":"Analysis of macromolecule resonances in 1H NMR spectra of human brain","volume":"32","author":"Behar","year":"1994","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib4","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1073\/pnas.95.26.15730","article-title":"Modulation of N-methyl-D-aspartate receptor function by glycine transport","volume":"95","author":"Bergeron","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib5","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1111\/j.1460-9568.2003.02996.x","article-title":"Active release of glycine or D-serine saturates the glycine site of NMDA receptors at the cerebellar mossy fibre to granule cell synapse","volume":"18","author":"Billups","year":"2003","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(99)00107-6","article-title":"In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists","volume":"59","author":"Bisaga","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2008.06.009","article-title":"Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia","volume":"91","author":"Boulay","year":"2008","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1176\/appi.ajp.2007.06081358","article-title":"The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments","volume":"164","author":"Buchanan","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/mrm.21450","article-title":"Measurement of glycine in human brain by triple refocusing 1H-MRS in vivo at 3.0T","volume":"59","author":"Choi","year":"2008","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004714-199002000-00027","article-title":"An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics","volume":"10","author":"Costa","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03033359","article-title":"Substance use disorders and schizophrenia: a question of shared glutamatergic mechanisms","volume":"10","author":"Coyle","year":"2006","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","article-title":"Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic","volume":"30","author":"Depoortere","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neuropharm.2005.10.014","article-title":"Glycine release in the substantia nigra: interaction with glutamate and GABA","volume":"50","author":"Dopico","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D'Souza","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.157.5.826","article-title":"Placebo-controlled trial of glycine added to clozapine in schizophrenia","volume":"157","author":"Evins","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF00969691","article-title":"Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study","volume":"20","author":"Flogel","year":"1995","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01244994","article-title":"Sodium-dependent release of exogenous glycine from preloaded rat hippocampal synaptosomes","volume":"93","author":"Galli","year":"1993","journal-title":"Journal of Neural Transmission. General Section"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1176\/ajp.153.12.1628","article-title":"D-cycloserine added to clozapine for patients with schizophrenia","volume":"153","author":"Goff","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR in Biomedicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00213-008-1271-z","article-title":"Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat","volume":"201","author":"Gozzi","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-4159.1982.tb08665.x","article-title":"Neurochemical studies of the mesolimbic dopaminergic pathway: glycinergic mechanisms and glycinergic-dopaminergic interactions in the rat ventral tegmentum","volume":"38","author":"Gundlach","year":"1982","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/A:1012328300037","article-title":"The role of glycineB binding site and glycine transporter (GlyT1) in the regulation of [3H]GABA and [3H]glycine release in the rat brain","volume":"26","author":"Harsing","year":"2001","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.euroneuro.2007.07.009","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine","volume":"18","author":"Hashimoto","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/glia.20322","article-title":"Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors","volume":"53","author":"Hayashi","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/mol.105.019174","article-title":"Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors","volume":"69","author":"Hejazi","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neuint.2007.01.002","article-title":"High-affinity glycine and glutamate transport in pig forebrain white and gray matter: a quantitative study","volume":"50","author":"Hejnum","year":"2007","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1192\/bjp.169.5.610","article-title":"Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia","volume":"169","author":"Heresco-Levy","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","article-title":"High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia","volume":"55","author":"Heresco-Levy","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.2004.067801","article-title":"Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices","volume":"560","author":"Huang","year":"2004","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mrm.20007","article-title":"Measurement of brain glutamate using TE-averaged PRESS at 3T","volume":"51","author":"Hurd","year":"2004","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib32","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","article-title":"Amelioration of negative symptoms in schizophrenia by glycine","volume":"151","author":"Javitt","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1461145701002590","article-title":"Adjunctive high-dose glycine in the treatment of schizophrenia","volume":"4","author":"Javitt","year":"2001","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.mp.4001552","article-title":"Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action","volume":"10","author":"Javitt","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/325529a0","article-title":"Glycine potentiates the NMDA response in cultured mouse brain neurons","volume":"325","author":"Johnson","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-008-1151-6","article-title":"Glycine and D:-serine, but not D:-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801","volume":"198","author":"Kanahara","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2007.07.033","article-title":"D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats","volume":"186","author":"Karasawa","year":"2008","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-3223(02)01828-0","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study","volume":"54","author":"Kaufman","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib41","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.2841759","article-title":"Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes","volume":"241","author":"Kleckner","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/syn.20286","article-title":"Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex","volume":"60","author":"Konradsson","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-008-1196-6","article-title":"Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia","volume":"200","author":"Labrie","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib44","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-3223(95)00585-4","article-title":"Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial","volume":"39","author":"Leiderman","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0771-6","article-title":"Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine","volume":"192","author":"Linn","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.104.067504","article-title":"Chronic morphine treatment alters N-methyl-D-aspartate receptors in freshly isolated neurons from nucleus accumbens","volume":"311","author":"Martin","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.jcp.0000245558.14284.aa","article-title":"Cerebral metabolic effects of intravenous glycine in healthy human subjects","volume":"26","author":"Neumeister","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmrb.1994.1048","article-title":"WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy","volume":"104","author":"Ogg","year":"1994","journal-title":"Journal of Magnetic Resonance B"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/ajp.156.1.145","article-title":"Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia","volume":"156","author":"Potkin","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mrm.20807","article-title":"In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0\u00a0T","volume":"55","author":"Prescot","year":"2006","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magnetic Resonance in Medicine"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib54","series-title":"LCModel and LCMgui User's Manual","first-page":"163","author":"Provencher","year":"2005"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib55","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1523\/JNEUROSCI.5077-03.2004","article-title":"Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis","volume":"24","author":"Roberto","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00002826-198910000-00006","article-title":"Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study","volume":"12","author":"Rosse","year":"1989","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0896-6273(00)80901-0","article-title":"Neuronal and glial glycine transporters have different stoichiometries","volume":"25","author":"Roux","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.15.1.1","article-title":"Amino acid and peptide absorption in patients with coeliac disease and dermatitis herpetiformis","volume":"15","author":"Silk","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jn\/128.3.606","article-title":"Catabolism dominates the first-pass intestinal metabolism of dietary essential amino acids in milk protein-fed piglets","volume":"128","author":"Stoll","year":"1998","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib60","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/BF00964352","article-title":"Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses","volume":"6","author":"Toth","year":"1981","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00965013","article-title":"Antagonism of phencyclidine-induced hyperactivity by glycine in mice","volume":"11","author":"Toth","year":"1986","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib62","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/ajp.156.11.1822","article-title":"D-serine added to clozapine for the treatment of schizophrenia","volume":"156","author":"Tsai","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1523\/JNEUROSCI.13-03-00981.1993","article-title":"Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types","volume":"13","author":"Urenjak","year":"1993","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2005.01.002","article-title":"The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect","volume":"48","author":"Vengeliene","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib65","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1203\/00006450-200208000-00024","article-title":"Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia","volume":"52","author":"Viola","year":"2002","journal-title":"Pediatric Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-3223(88)90093-5","article-title":"Glycine therapy of schizophrenia","volume":"23","author":"Waziri","year":"1988","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2004.01.013","article-title":"Effects of typical and atypical antipsychotics on human glycine transporters","volume":"71","author":"Williams","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2006.04.016","article-title":"A shared vesicular carrier allows synaptic corelease of GABA and glycine","volume":"50","author":"Wojcik","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib69","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/jn\/128.8.1249","article-title":"Intestinal mucosal amino acid catabolism","volume":"128","author":"Wu","year":"1998","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.pscychresns.2009.03.004_bib70","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","article-title":"Glycine transporters are differentially expressed among CNS cells","volume":"15","author":"Zafra","year":"1995","journal-title":"Journal of Neuroscience"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492709000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492709000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:59:28Z","timestamp":1685044768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492709000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0925492709000663"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2009.03.004","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}